Cargando…
Fibrinolysis Shutdown in COVID-19-Infected Patients Can Result from Iron-Induced Stabilization of Fibril Clots
Autor principal: | Sukhomlin, Tatiana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American College of Surgeons. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506364/ https://www.ncbi.nlm.nih.gov/pubmed/32972832 http://dx.doi.org/10.1016/j.jamcollsurg.2020.08.170 |
Ejemplares similares
-
Fibrinolysis Shutdown and Thrombosis in Severe COVID-19
por: Seheult, Jansen N., et al.
Publicado: (2020) -
The Procoagulant Effect of COVID-19 on the Thrombotic Risk of Patients with Hip Fractures Due to Enhanced Clot Strength and Fibrinolysis Shutdown
por: Tsantes, Andreas G., et al.
Publicado: (2021) -
Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection
por: Wright, Franklin L., et al.
Publicado: (2020) -
Hyperfibrinolysis and fibrinolysis shutdown in patients with traumatic brain injury
por: Nakae, Ryuta, et al.
Publicado: (2022) -
Clot Structure and Fibrinolysis in Thrombosis and Hemostasis
por: Bagoly, Zsuzsa, et al.
Publicado: (2017)